US Patent Issued to Regeneron Pharmaceuticals on Nov. 3 for "Compositions and methods for reducing bioburden in chromatography" (New York, California Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,069, issued on Nov. 3, was assigned to Regeneron Pharmaceuticals Inc..

"Compositions and methods for reducing bioburden in chromatography" was invented by Nathan L. Mao (Cohoes, N.Y.), Wenbin Qi (Carlsbad, Calif.), Bernhard Schilling (Hudson, N.Y.) and Scott Carver (Wynantskill, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides methods for microbial bioburden reduction of various chromatography matrices, including bioburden reduction in the context of large-scale Protein A-based affinity chromatography columns."

The patent was filed on July 5, 2023, under Application No. 18/218,532.

*For further information, including image...